Status
Conditions
Treatments
About
The purpose of this program is to provide elexacaftor(ELX, VX-445)/tezacaftor(TEZ)/ivacaftor(IVA) combination therapy to CF patients in critical need who are 12 years of age and older, heterozygous for F508del and a minimal function (MF) mutation in response to unsolicited physician requests.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other protocol defined Inclusion/Exclusion criteria may apply
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal